BMC Microbiology,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: April 5, 2024
Abstract
Obesity
is
a
metabolic
disorder
closely
associated
with
profound
alterations
in
gut
microbial
composition.
However,
the
dynamics
of
species
composition
and
functional
changes
microbiome
obesity
remain
to
be
comprehensively
investigated.
In
this
study,
we
conducted
meta-analysis
metagenomic
sequencing
data
from
both
obese
non-obese
individuals
across
multiple
cohorts,
totaling
1351
fecal
metagenomes.
Our
results
demonstrate
significant
decrease
richness
diversity
bacteriome
virome
patients.
We
identified
38
bacterial
including
Eubacterium
sp.
CAG:274,
Ruminococcus
gnavus
,
eligens
Akkermansia
muciniphila,
1
archaeal
species,
Methanobrevibacter
smithii
that
were
significantly
altered
obesity.
Additionally,
observed
abundance
five
viral
families:
Mesyanzhinovviridae
Chaseviridae
Salasmaviridae
Drexlerviridae
Casjensviridae
.
Functional
analysis
indicated
distinct
signatures
as
primary
driver
for
function
enrichment
obesity,
muciniphila
bicirculans
siraeum
drivers
healthy
control
group.
our
suggest
antibiotic
resistance
genes
virulence
factors
may
influence
development
Finally,
demonstrated
vOTUs
achieved
diagnostic
accuracy
an
optimal
area
under
curve
0.766
distinguishing
controls.
findings
offer
comprehensive
generalizable
insights
into
features
potential
guide
microbiome-based
diagnostics.
Nutrients,
Journal Year:
2021,
Volume and Issue:
13(9), P. 3208 - 3208
Published: Sept. 15, 2021
Chronic
inflammation
plays
a
central
role
in
the
pathophysiology
of
various
non-communicable
diseases.
Dietary
interventions
can
reduce
inflammation,
part
due
to
their
effect
on
gut
microbiome.
This
systematic
review
aims
determine
dietary
interventions,
specifically
fiber
intake,
chronic
inflammatory
diseases
and
It
form
hypotheses
potential
mediating
effects
microbiome
disease
outcomes
after
changes.
Included
were
clinical
trials
which
performed
intervention
with
whole
diet
change
or
supplement
(>5
g/day)
investigated
patients
diagnosed
such
as
cardiovascular
(CVD),
type
2
diabetes
(T2DM),
autoimmune
(e.g.,
rheumatoid
arthritis
(RA),
bowel
(IBD)).
The
30
articles
met
inclusion
criteria
had
an
overall
moderate
high
risk
bias
too
heterogeneous
perform
meta-analysis.
stratified
based
intake:
low
fiber,
supplemental
fiber.
Overall,
but
most
pronounced
T2DM,
high-fiber
plant-based
consistently
more
effective
at
reducing
disease-specific
pathogenic
bacteria,
well
increasing
alpha
diversity
short-chain
fatty
acid
(SCFA)-producing
compared
other
diets
supplements.
Nutrients,
Journal Year:
2021,
Volume and Issue:
13(7), P. 2234 - 2234
Published: June 29, 2021
Gut
microbiota
dysbiosis
is
a
common
feature
in
colorectal
cancer
(CRC)
and
inflammatory
bowel
diseases
(IBD).
Adoption
of
the
Mediterranean
diet
(MD)
has
been
proposed
as
therapeutic
approach
for
prevention
multiple
diseases,
one
its
mechanisms
action
modulation
microbiota.
We
aimed
to
determine
whether
MD
can
be
used
preventive
measure
against
inflammation-related
gut,
based
on
capacity
modulate
local
A
joint
meta-analysis
publicly
available
16S
data
derived
from
subjects
following
or
other
diets
patients
with
CRC,
IBD,
gut-related
was
conducted.
observed
that
associated
enriched
bacteria
promote
an
anti-inflammatory
environment
but
low
taxa
pro-inflammatory
properties
capable
altering
intestinal
barrier
functions.
found
opposite
trend
including
cancer.
Some
these
differences
were
maintained
even
when
compared
healthy
controls
without
defined
diet.
Our
findings
highlight
unique
effects
gut
suggest
integrating
principles
into
person's
lifestyle
may
serve
method
diseases.
Theranostics,
Journal Year:
2021,
Volume and Issue:
11(12), P. 5778 - 5793
Published: Jan. 1, 2021
Prior
chronic
treatment
with
statins
has
been
shown
to
be
associated
more
favorable
outcomes
in
patients
acute
coronary
syndrome
(ACS).
Specific
changes
the
gut
microbiota
and
microbial
metabolites
have
influence
progression
of
artery
disease.
However,
critical
metabolomic
cardiovascular
protective
effects
ACS
remain
elusive.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2021,
Volume and Issue:
11
Published: Aug. 17, 2021
Frailty
is
a
common
geriatric
syndrome
that
diagnosed
and
staged
based
mainly
on
symptoms.
We
aimed
to
evaluate
frailty-related
alterations
of
the
intestinal
permeability
profile
fecal
microbiota
healthy
frail
older
adults
identify
microbial
biomarkers
this
syndrome.We
collected
serum
samples
from
94
community-dwelling
adults,
along
with
anthropometric,
medical,
mental
health,
lifestyle
data.
Serum
inflammatory
cytokines
IL-6
HGMB1
biomarker
zonulin
were
measured
using
enzyme-linked
immunosorbent
assays.
The
16S
rRNA
amplicon
sequencing
method
was
performed
determine
composition
microbiota.
analyzed
diversity
differences
gut
in
two
groups
assessed
relationship
between
changes
structure
clinical
biomarkers.Older
frailty
showed
higher
concentrations
IL-6,
HGMB1,
zonulin.
Although
there
no
statistically
significant
index
evenness
indices
or
species
richness
groups,
we
found
differences.
Compared
control
group,
group
had
levels
Akkermansia,
Parabacteroides,
Klebsiella
lower
commensal
genera
Faecalibacterium,
Prevotella,
Roseburia,
Megamonas,
Blautia.
Spearman's
correlation
analysis
intergenus
interactions
more
controls
than
frailty.
Escherichia/Shigella,
Pyramidobacter,
Alistipes,
Akkermansia
positively
correlated
while
Roseburia
negatively
IL-6.
Alistipes
be
HGMB1.
linked
increased
level
factors
permeability.Frailty
associated
These
findings
might
aid
development
probiotics
microbial-based
therapies
for
With
the
increase
in
total
coronavirus
disease
2019
(COVID-19)
infection
cases,
post-acute
COVID-19
syndrome,
defined
as
experiencing
ongoing
health
problems
4
or
more
weeks
after
first
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
infection,
has
become
a
new
arising
public
concern.
As
part
of
gastrointestinal
symptoms
might
be
associated
with
dysbiosis
gut
microbiota,
which
potential
to
target
for
intervention.
In
this
study,
patient
long-lasting
was
provided
2-month
expanded
access
high-fiber
formula
investigational
drug
(IND)
status
developed
alleviate
COVID-19-related
by
modulating
microbiota.
Symptoms
including
"loss
appetite,"
palpitation,
and
anxiety
were
significantly
alleviated
end
The
medication
dosage
controlling
nausea
decreased
during
serum
lipid
profile,
insulin
level,
leptin
level
improved
compared
baseline
values.
Significant
structural
changes
patient's
microbiota
reduced
microbial
fermentation
activity
small
intestine
found
Eighteen
amplicon
sequence
variants
(ASVs)
V4
region
16S
rRNA
gene
responded
nutritional
Six
out
18
ASVs
also
negatively
correlated
symptom
severity/medication
dosage.
Five
six
(ASV0AKS_Oscillibacter,
ASV009F_Anaerofustis,
ASV02YT_Blautia,
ASV07LA_Blautia,
ASV0AM6_Eubacterium
hallii)
short-chain
fatty
acid
(SCFA)-producing
bacteria,
alleviation
symptoms.
Our
study
indicates
feasibility
alleviating
patients
way
modulation
their
IMPORTANCE
It
evident
that
care
does
not
at
time
negative
SARS-CoV-2
detection,
number
increases
an
ever-increasing
infected
population.
This
case
report
shows
possibility
via
microbiota-targeted
promising
strategy,
it
only
improve
quality
life
but
reduce
burden
system
when
pandemic
is
sight.
Gut Microbes,
Journal Year:
2023,
Volume and Issue:
15(1)
Published: July 5, 2023
Compelling
evidence
has
tightly
linked
gut
microbiota
with
host
metabolism
homeostasis
and
inspired
novel
therapeutic
potentials
against
metabolic
diseases
(e.g.,
hyperlipidemia).
However,
the
regulatory
profile
of
individual
bacterial
species
strain
on
lipid
remains
largely
unknown.
Herein,
we
performed
a
large-scale
screening
2250
human
strains
(186
species)
for
lipid-decreasing
activity.
Different
in
same
usually
displayed
distinct
lipid-modulatory
actions,
showing
evident
strain-specificity.
Among
tested
strains,
Blautia
producta
exhibited
most
potency
to
suppress
cellular
accumulation
effectively
ameliorated
hyperlipidemia
high
fat
diet
(HFD)-feeding
mice.
Taking
joint
comparative
approach
pharmacology,
genomics
metabolomics,
identified
an
anteiso-fatty
acid,
12-methylmyristic
acid
(12-MMA),
as
key
active
metabolite
Bl.
Producta.
In
vivo
experiment
confirmed
that
12-MMA
could
exert
potent
hyperlipidemia-ameliorating
efficacy
improve
glucose
via
activating
G
protein-coupled
receptor
120
(GPR120).
Altogether,
our
work
reveals
previously
unreported
microbes
at
level,
emphasizes
strain-specific
function
bacteria,
provides
possibility
develop
microbial
therapeutics
based
its
metabolite.